This is the first study that really not just one endpoint looking at blood pressure, but just measuring it continuously
Metabolomics of arterial stiffness
Studies show it typically leads to about a 4% drop in body weight over six months
Women facing hormonal weight resistance: Conditions like PCOS, perimenopause, or thyroid-related changes can make weight loss incredibly challenging
In the Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes published in 2024, it was recommended to start GLP-1 RA sodium-glucose co-transporter 2 inhibitors (SGLT2i) in patients with T2DM and ASCVD, while also commenting upon noted benefit in specifically HFpEF as well [53]
Omadacycline, an aminomethylcycline that is also the first of its kind, can get around the most common tetracycline resistance mechanisms while still active against Gram-positive bacteria, including MRSA [140]